Consolidated Statement of Operations - USD ($)	12 Months Ended
	Oct. 31, 2020	Oct. 31, 2019
Text Block [Abstract]
Revenues	$ 11,528,813	$ 15,046,149
Cost of expenses:
Cost of revenues	6,187,442	8,368,025
Research and development expenses	338,001	556,261
Selling, general, and administrative expenses	6,466,682	9,253,583
Impairment charges	9,874,281	0
Operating Expenses	22,866,406	18,177,869
Loss from operations	(11,337,593)	(3,131,720)
Interest expense - related party	906,567	715,933
Other loss	22,761	0
Loss before income taxes	(12,266,921)	(3,847,653)
Provision/(Benefit) for income taxes	36,918	(10,320)
Net loss	$ (12,303,839)	$ (3,837,333)
Net loss per common share - basic	$ (1.60)	$ (0.50)
Net loss per common share - diluted	$ (1.60)	$ (0.50)
Weighted average number of common shares outstanding - basic	7,710,561	7,696,091
Weighted average number of common shares outstanding - diluted	7,710,561	7,696,091